Skip to main content
Article

Molecular Mechanism of Action of Microtubule-Stabilizing Anticancer Agents

A.E. ProtaBiomolecular Research, Paul Scherrer Institut, Villigen PSI, SwitzerlandKatja BargstenBiomolecular Research, Paul Scherrer Institut, Villigen PSI, SwitzerlandDidier ZurwerraDepartment of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology (ETH) Zürich, Zürich, SwitzerlandJessica J. FieldCentre for Biodiscovery, Victoria University of Wellington, Wellington, New ZealandJ. Fernando Dı́azChemical and Physical Biology, Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas CIB-CSIC, Madrid, SpainKarl‐Heinz AltmannDepartment of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology (ETH) Zürich, Zürich, SwitzerlandMichel O. SteinmetzBiomolecular Research, Paul Scherrer Institut, Villigen PSI, Switzerland
2013en
ABI

Abstract

Microtubule-stabilizing agents (MSAs) are efficacious chemotherapeutic drugs widely used for the treatment of cancer. Despite the importance of MSAs for medical applications and basic research, their molecular mechanisms of action on tubulin and microtubules remain elusive. We determined high-resolution crystal structures of αβ-tubulin in complex with two unrelated MSAs, zampanolide and epothilone A. Both compounds were bound to the taxane pocket of β-tubulin and used their respective side chains to induce structuring of the M-loop into a short helix. Because the M-loop establishes lateral tubulin contacts in microtubules, these findings explain how taxane-site MSAs promote microtubule assembly and stability. Further, our results offer fundamental structural insights into the control mechanisms of microtubule dynamics.

Identifiers

Citations and references

Cited by 20 references